+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Keytruda"

KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
KEYTRUDA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KEYTRUDA Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Melanoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Metastatic Uveal Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Uveal Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
KEYTRUDA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KEYTRUDA Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
From
From
From
Melanoma Disease Coverage Forecast and Market Analysis - Product Thumbnail Image

Melanoma Disease Coverage Forecast and Market Analysis

  • Report
  • March 2021
  • 84 Pages
  • Global
Keytruda (pembrolizumab; Merck & Co) Drug Overview 2019 - Product Thumbnail Image

Keytruda (pembrolizumab; Merck & Co) Drug Overview 2019

  • Drug Pipelines
  • September 2019
  • 141 Pages
  • Global
Torisel (temsirolimus; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Torisel (temsirolimus; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 24 Pages
  • Global
Alimta - Product Thumbnail Image

Alimta

  • Report
  • August 2018
  • 27 Pages
  • Global
From
From
Melanoma - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Melanoma - Global Drug Forecast and Market Analysis to 2029

  • Report
  • April 2021
  • 131 Pages
  • Global
From
Malignant Melanoma: Update Bulletin - Product Thumbnail Image

Malignant Melanoma: Update Bulletin

  • Newsletter
  • May 2024
  • Global
From
Keytruda- Drug Insight, 2019 - Product Thumbnail Image

Keytruda- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 20 Results (Page 1 of 1)
Loading Indicator

Keytruda is a type of skin cancer drug used to treat melanoma, a type of skin cancer. It is a type of immunotherapy, which works by helping the body’s immune system recognize and attack cancer cells. Keytruda is a monoclonal antibody, which means it is designed to target a specific protein on the surface of cancer cells. It is approved for use in adults and children with advanced melanoma, and is also being studied for use in other types of cancer. Keytruda is one of several skin cancer drugs on the market. Other drugs used to treat melanoma include Yervoy, Opdivo, and Tecentriq. These drugs are all immunotherapies, and work in different ways to help the body fight cancer. Companies in the Keytruda market include Merck, which manufactures the drug, as well as Bristol-Myers Squibb, Roche, and AstraZeneca. These companies are all involved in the research, development, and marketing of Keytruda and other skin cancer drugs. Show Less Read more